Missing/wrong data?
Log in to edit
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
scientific article published on 18 December 2017
Author/s
author: Alain Ravaud, Ugo De Giorgi, Nicholas J. Vogelzang, Michiel S. van der Heijden
Work details
Publication date
December 18, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.